Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
Allergan Aesthetics announced the U.S. launch of AA Signature, a collection of patient-centric, multimodal consultation approaches that leverage Allergan Medical Institute (AMI) resources and Allergan Aesthetics products.
The program will launch with AA Signature™: SKIN360, its first patient-centric consultation approach featuring Skinvive by Juvéderm®, SkinMedica® HA5® Hydra Collagen Hydrator with Vegan Collagen, and Botox® Cosmetic (onabotulinumtoxinA).
“At Allergan Aesthetics, we believe leadership means not only advancing science and innovation but also equipping providers with the tools they need to succeed in a rapidly evolving market,” said Nicole Mowad-Nassar, senior vice president, AbbVie and president, Global Allergan Aesthetics, in a release. “AA Signature represents a new approach to treatment planning, helping HCPs deliver personalized, multimodal assessments backed by Allergan Aesthetics’ robust product portfolio. By enabling more meaningful patient consultations and individualized treatment journeys, we are helping shape the future of aesthetic medicine.”
AA Signature is grounded in the art of consultation and provides HCPs with guidance on how to conduct structured, comprehensive facial assessments. Allergan research shows that 96% of patients are interested in a comprehensive assessment and at the same time, practices that take a comprehensive, multimodal approach to treatment planning see 68% higher patient retention than those treating a single concern. Thorough consultations are critical to informing treatment plans that level set expectations to help patients achieve their individual aesthetic goals.
Allergan Aesthetics conducted a brand-agnostic, category-wide study to examine the need for deeper patient education about the value of comprehensive consultations. The findings showed eight out of 10 patients move forward with aesthetic treatment after receiving a comprehensive assessment and aligning with their provider on a treatment plan incorporating two or more in-office products or procedures.
AA Signature: SKIN360 is tailored for patients who desire smoother, more hydrated skin. This assessment approach is designed to support HCPs as they explore different types of treatments to achieve patients’ aesthetic goals with products in the Allergan Aesthetics portfolio. As part of the consultation process, aesthetic specialists may consider three products in an AA Signature: SKIN360 assessment:
- Skinvive by Juvéderm® improves cheek skin smoothness, leading to increased hydration.
- SkinMedica® HA5® Hydra Collagen Hydrator with Vegan Collagen supports immediate and long-lasting hydration, as well as visibly plump, dewy, healthier-looking skin.
- Botox® Cosmetic is an FDA-approved prescription medicine that works beneath the skin’s surface to temporarily improve the appearance of moderate to severe platysma bands associated with platysma muscle activity, forehead lines, lateral canthal lines, and glabellar lines in adults.
Subsequent aesthetic consultation protocols will debut through 2027 and will address key patient concerns, including lift, structure, skin firmness, and facial definition. Providers interested in additional resources and training materials may speak with their Allergan Aesthetics business development representative for more information.
